Search by...
-
8MarPortolano Cavallo invests in Private Equity with new partner Andrea GrittiIn the last two years, Portolano Cavallo has handled approximately 80 M&A transactions with double-digit revenue growth in recent years.Article filed under: Private Equity
-
24FebIn the United States, Amazon launched RxPass, a subscription for online purchase of prescription drugs: Could it work in Italy?A few weeks ago, the company introduced a new subscription service that allows subscribers to purchase more than fifty different prescription medicines for a low fixed months fee. Why this would be prohibited in Italy.
-
-
25JanHow Covid changed telemedicine in Italy: Current status and next stepsDurante e dopo la pandemia, la telemedicina è stata al centro di una serie di importanti interventi del legislatore. A questi si aggiungono ora i fondi del PNRR per 1 mld di euro. Tali risorse e il ruolo delle regioni nel garantirne l’implementazione saranno di fondamentale importanza.
-
-
23JanThe Italian Parliament approved Law no. 6 of January 13, 2023, setting forth new provisions applicable to distribution agreements in the automotive industryOn January 19, 2023, Italian Law No. 6 of January 13, 2023, containing amendments to Italian Law No. 108 of August 5, 2022, entered into force.Article filed under: Automotive & Mobility
-
-
16JanUrban air mobility: Implementation of the U-space regulatory packageWithin the context of legislative developments on urban air mobility, as of January 26, 2023, the three implementing regulations adopted by the European Commission in April 2021 will come into force in the European UnionArticle filed under: Automotive & Mobility
-
-
21DecClinical trials and sanctions in relation to Regulation 2014/536, national rules, and contract standardsThe European rules on drug trials do not include provisions for sanctions, but instead leave it up to Member States to outline an effective sanctioning framework.
-
-
1DecReuse of personal data for research purposes in light of the most recent guidelines from the GaranteIn the context of clinical studies, companies are concerned about the legal conditions for use for research purposes of previously collected personal data, including data from third parties.
-
-
20OctIRCCS reform: Upcoming changes with regard to researchThe regulation of Scientific Institutes for Research, Hospitalization, and Health Care (“Istituti di Ricovero e Cura a Carattere Scientifico,” “IRCCS” or “Institutes”) is undergoing a major transformation in Italy.
-
-
21SepDecentralized clinical trials: The current scenario and forthcoming European guidelinesOn August 30, the European Commission (EC), heads of medicines agencies (HMAs), and European Medicines Agency (EMA) published the 2022-2026 work plan for the Accelerating Clinical Trials in the EU (ACT EU) initiative.
-
-
5AugItalian amendments on automotive distribution agreementsOn August 5, 2022, the Official Journal published Italian law no. 108, converting Law Decree no. 68/2022, which contains urgent provisions for the safety and development of infrastructure, transport, and sustainable mobility, as well as for major events and for the functionality of the Ministry of Sustainable Infrastructure and Mobility.Article filed under: Automotive & Mobility
-
